Infanrix Hexa

Infanrix Hexa Description

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig
Full Prescribing Info
Description
After reconstitution, 1 dose (0.5 ml) contains: Diphtheria toxoid1 not less than 30 International Units (IU).
Tetanus toxoid1 not less than 40 International Units (IU).
Bordetella pertussis antigens: Pertussis toxoid (PT)1 25 micrograms; Filamentous Haemagglutinin (FHA)1 25 micrograms; Pertactin (PRN)1 8 micrograms.
Hepatitis B surface antigen (HBs)2,3 10 micrograms.
Poliovirus (inactivated) (IPV): type 1 (Mahoney strain)4 40 D-antigen unit; type 2 (MEF-1 strain)4 8 D-antigen unit; type 3 (Saukett strain)4 32 D-antigen unit.
Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate, PRP)3 10 micrograms conjugated to tetanus toxoid as carrier protein approximately 25 micrograms.
1adsorbed on aluminium hydroxide, hydrated (Al(OH)3) 0.5 milligrams Al3+.
2produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology.
3adsorbed on aluminium phosphate (AlPO4) 0.32 milligrams Al3+.
4propagated in VERO cells.
The vaccine may contain traces of formaldehyde, neomycin and polymyxin which are used during the manufacturing process (see Contraindications).
Excipients/Inactive Ingredients: Hib powder: Lactose anhydrous.
DTPa-HBV-IPV suspension: Sodium chloride (NaCl); Medium 199 containing principally amino acids, mineral salts, vitamins; Water for injections.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in